Limited Competition: Renewal Applications for Technology Development for New Affinity Reagents Against the Human Proteome (U01)
The summary for the Limited Competition: Renewal Applications for Technology Development for New Affinity Reagents Against the Human Proteome (U01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Renewal Applications for Technology Development for New Affinity Reagents Against the Human Proteome (U01): The NIH Common Fund Protein Capture Reagents Program (PCRP) aims to develop over time the capacity to generate a community resource of high quality renewable affinity reagents for all human proteins (see https://commonfund.nih.gov/proteincapture/). This Funding Opportunity Announcement (FOA) is a component of the PCRP, and it seeks renewal applications to cooperative agreements that were funded through RFA-RM-10-018.
Federal Grant Title: | Limited Competition: Renewal Applications for Technology Development for New Affinity Reagents Against the Human Proteome (U01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-RM-14-002 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.310 |
CFDA Descriptions: | Trans-NIH Research Support |
Current Application Deadline: | Apr 25, 2014 |
Original Application Deadline: | Apr 25, 2014 |
Posted Date: | Feb 12, 2014 |
Creation Date: | Feb 12, 2014 |
Archive Date: | May 26, 2014 |
Total Program Funding: | $6,000,000 |
Maximum Federal Grant Award: | $2,000,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following:
Faith-based or Community-based Organizations; Eligibility is limited to cooperative agreement awards that were funded through RFA-RM-10-018 "Technology Development for New Affinity Reagents Against the Human Proteome (U54)."
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-14-002.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial No...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
- • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
- • NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
- • Using Metabolomics to Investigate Biological Pathways and Networks (R01)
- • Assay Development for High Throughput Molecular Screening (R21)
- • Membrane Protein Production and Structure Determination (R01)
- More Grants from the National Institutes of Health
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...